Anteris Technologies Global Corp.

Healthcare

NASDAQ:AVR · NASDAQ Global Market

Market Cap $359.79M Beta 0.73 P/E (TTM) -2.3
$9.78 -0.16%

-$0.02 today

52W Low $2.85High $10.14

Vol 1.45M · Avg 1.18M

EPS (TTM) -$4.04Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+157.37%

Period High

$9.78

Period Low

$2.90

Latest

$9.78

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health
CY

Cybin Inc.

CYBN

$413.02M

Nkarta, Inc.

Nkarta, Inc.

NASDAQ:NKTX

$194.25M

Anika Therapeutics, Inc.

Anika Therapeutics, Inc.

NASDAQ:ANIK

$188.01M

MaxCyte, Inc.

MaxCyte, Inc.

NASDAQ:MXCT

$127.47M

Lucid Diagnostics Inc.

Lucid Diagnostics Inc.

NASDAQ:LUCD

$105.88M

Owlet, Inc.

Owlet, Inc.

NYSE:OWLT

$85.59M

LENSAR, Inc.

LENSAR, Inc.

NASDAQ:LNSR

$70.93M

SA

Cassava Sciences, Inc.

SAVA

$63.77M

AT

Atlantic International Corp.

NASDAQ:ATLN

$41.66M

AR

Accuray Incorporated

ARAY

$40.47M

What is the latest AVR filing?

The latest filing shown is 4 dated Jun 9, 2026.

How many recent filings does AVR have?

Intrinsic Alpha currently shows 20 recent filings for AVR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.